<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two cases of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) were treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF) </plain></SENT>
<SENT sid="1" pm="."><plain>In both cases, an increase of peripheral neutrophil counts was noted with a peak within 12 hr after the rhG-CSF administration </plain></SENT>
<SENT sid="2" pm="."><plain>Neutrophils with ring shaped or hypersegmented nuclei were noted in the peripheral blood during the treatment, and they disappeared promptly after discontinuation of the therapy </plain></SENT>
<SENT sid="3" pm="."><plain>The results indicate that the rhG-CSF might have mobilizing and differentiating effects on neutrophils derived from the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> clone </plain></SENT>
</text></document>